What is Dyne Therapeutics, Inc.'s net investment in lease?

Dyne Therapeutics, Inc. (DYN) reported net investment in lease of $19.65M in Q1 2026.

How has Dyne Therapeutics, Inc.'s net investment in lease changed year-over-year?

Dyne Therapeutics, Inc.'s net investment in lease decreased by 17.7% year-over-year, from $23.88M to $19.65M.

What is the long-term trend for Dyne Therapeutics, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s net investment in lease has grown at a 96.9% compound annual growth rate (CAGR), from $700K to $20.74M.

Dyne Therapeutics, Inc. DYN Net Investment in Lease

Net Investment in Lease at other companies

Ionis PharmaceuticalsIONS

——

Arrowhead ResearchARWR

——

Edgewise Therapeutics, Inc.EWTX

——

PTC TherapeuticsPTCT

——

Scholar RockSRRK

——

Catalyst PharmaceuticalCPRX

——

Other financials

Income statement

See full

Operating income-$125.3M-2.4%

Net income-$120.9M-4.8%

EPS (diluted)-$0.73+30.5%

Balance sheet

See full

Cash & equivalents$753.1M+59.5%

Total debt$168.7M+623%

Total equity$865.1M+29.3%

Total assets$1.1B+49.8%

Cash flow

See full

Operating cash flow-$144.9M-36.9%

CapEx$221.0K-77.5%

Free cash flow-$145.1M-35.8%

Valuation

See full

Market cap$3.35B+153%

Returns & leverage

See full

Return on equity-58.9%-4.4pp

Debt / equity0.2×+0.2×

Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s net investment in lease?: Dyne Therapeutics, Inc. (DYN) reported net investment in lease of $19.65M in Q1 2026.
How has Dyne Therapeutics, Inc.'s net investment in lease changed year-over-year?: Dyne Therapeutics, Inc.'s net investment in lease decreased by 17.7% year-over-year, from $23.88M to $19.65M.
What is the long-term trend for Dyne Therapeutics, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s net investment in lease has grown at a 96.9% compound annual growth rate (CAGR), from $700K to $20.74M.